Dr. Melissa Bourgeois from Merck Animal Health joins us to talk about the exciting new launch of a monoclonal antibody gilvetmab that will allow veterinary oncologists to use the checkpoint inhibitor to recognize and fight cancer cells.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
